Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hommer, Daniel W.
Zahn, Theodore P.
Pickar, David
and
van Kammen, Daniel P.
1984.
Prazosin, a specific alpha1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients.
Psychiatry Research,
Vol. 11,
Issue. 3,
p.
193.
Eccleston, D.
Fairbairn, A. F.
Hassanyeh, F.
McClelland, H. A.
and
Stephens, D. A.
1985.
The Effect of Propranolol and Thioridazine on Positive and Negative Symptoms of Schizophrenia.
British Journal of Psychiatry,
Vol. 147,
Issue. 6,
p.
623.
Roberts, J. E.
Edwards, J. G.
Checkley, S.
Crammer, J. L.
Cutting, J. C.
Lader, M. H.
and
Murray, R. M.
1986.
A Case of Resistant Schizophrenia.
British Journal of Psychiatry,
Vol. 149,
Issue. 6,
p.
789.
Steinert, J
Neder, A
Erba, E
Pugh, C R
Robinson, C
and
Priest, R G
1986.
A Comparative Trial of Depot Pipothiazine.
Journal of International Medical Research,
Vol. 14,
Issue. 2,
p.
72.
HARA, Chiaki
and
OGAWA, Nobuya
1986.
Potentiation of Haloperidol-induced Catalepsy by Beta-Adrenoceptor Antagonists in Mice.
Japanese Journal of Pharmacology,
Vol. 42,
Issue. 1,
p.
79.
Manchanda, Rahul
and
Hirsch, Steven R.
1986.
Does Propranolol have an Antipsychotic Effect?.
British Journal of Psychiatry,
Vol. 148,
Issue. 6,
p.
701.
Hollister, Leo E.
1986.
Old and new approaches to drug treatment of schizophrenia.
Drug Development Research,
Vol. 9,
Issue. 1,
p.
9.
Meltzer, Herbert Y.
1986.
Novel approaches to the pharmacotherapy of schizophrenia.
Drug Development Research,
Vol. 9,
Issue. 1,
p.
23.
Montgomery, Stuart A.
and
Green, Mary C. D.
1988.
The use of cholecystokinin in schizophrenia: a review.
Psychological Medicine,
Vol. 18,
Issue. 3,
p.
593.
Gelernter, Joel
and
van Kammen, Daniel P.
1988.
Vol. 29,
Issue. ,
p.
309.
O’Callaghan, Mark A. J.
1988.
Biological Contributions to Crime Causation.
p.
246.
Corn, T. H.
and
Haigh, J. R. M.
1990.
Early Phase Drug Evaluation in Man.
p.
443.
Marder, Stephen R.
Wirshing, William C.
and
Van Putten, Theodore
1991.
Drug treatment of schizophrenia.
Schizophrenia Research,
Vol. 4,
Issue. 2,
p.
81.
Rifkin, Arthur
1993.
Pharmacologic Strategies in the Treatment of Schizophrenia.
Psychiatric Clinics of North America,
Vol. 16,
Issue. 2,
p.
351.
Wirshing, William C.
Ames, Donna
Marder, Stephen R.
and
Hicks-Gray, Tara
1994.
Handbook of Aggressive and Destructive Behavior in Psychiatric Patients.
p.
203.
Reynolds, Gavin P.
and
Czudek, Carole
1995.
Vol. 32,
Issue. ,
p.
461.
Ohashi, Kazuyo
Hamamura, Takashi
Lee, Youmei
Fujiwara, Yutaka
and
Kuroda, Shigetoshi
1998.
Propranolol attenuates haloperidol-induced Fos expression in discrete regions of rat brain: possible brain regions responsible for akathisia.
Brain Research,
Vol. 802,
Issue. 1-2,
p.
134.
Cheine, Maxim V.
Wahlbeck, Kristian
and
Rimón, Mnan
1999.
Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis.
International Journal of Psychiatry in Clinical Practice,
Vol. 3,
Issue. 3,
p.
159.
Wahlbeck, Kristian
Cheine, Maxim V.
Gilbody, Simon
and
Ahonen, Juha
2000.
Efficacy of β-blocker supplementation for schizophrenia: a systematic review of randomized trials.
Schizophrenia Research,
Vol. 41,
Issue. 2,
p.
341.
Maoz, Gadi
Stein, Daniel
Meged, Sorin
Kurzman, Larisa
Levine, Joseph
Valevski, Avi
Aviv, Alex
Sirota, Pinhas
Kraus, Ruth
Weizman, Avi
and
Berger, Barry D.
2000.
The Antiaggressive Action of Combined Haloperidol-Propranolol Treatment in Schizophrenia.
European Psychologist,
Vol. 5,
Issue. 4,
p.
312.
eLetters
No eLetters have been published for this article.